Skip to main content
logo
Ocean Biomedical, Inc. (OCEA)
OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
Sep 28, 2026, 4:00 PM EST

Ocean Biomedical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-30.72-9.48-114.47-17.36-62.34-1.65
Other Amortization
0.350.280.63---
Loss (Gain) on Equity Investments
1.063.30.71---
Stock-Based Compensation
0.750.751.8712.3856.55-
Other Operating Activities
23.27-0.07100.651.18--
Change in Accounts Payable
0.960.871.232.81--
Change in Other Net Operating Assets
0.280.17-0.05-4.741.59
Operating Cash Flow
-4.05-4.18-9.43-0.99-1.05-0.06
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Short-Term Debt Issued
--8.260.74--
Long-Term Debt Issued
-3.40.65---
Total Debt Issued
4.313.48.910.74--
Short-Term Debt Repaid
---2.1---
Total Debt Repaid
---2.1---
Net Debt Issued (Repaid)
4.313.46.810.74--
Issuance of Common Stock
--14.26-1.02-
Other Financing Activities
---10.670.230.10.06
Financing Cash Flow
4.313.410.40.971.110.06

Net Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Cash Flow
0.26-0.780.97-0.030.06-

Free Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Levered Free Cash Flow
-5.34-1.641.174.6122.33-
Unlevered Free Cash Flow
-4.6-0.641.655.3922.33-

Additional Metrics

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Change in Working Capital
1.241.041.182.814.741.59